News

The U.S. approved a twice-yearly HIV prevention shot that’s highly effective, but concerns about cost, access, and global ...
The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical ...
Analysts at Oppenheimer, BMO, Morgan Stanley, and Mizuho weighed in with positive long-term views, though Oppenheimer flagged ...